文献速递中药与中成药合理使用中医内科

活性氧:植物药调控氧化应激治疗糖脂代谢紊乱的重要突破点

Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism.
PubMed 文献 · Front Pharmacol · 2023-05-12

该综述检索Web of Science和PubMed 2013至2022年文献,总结植物药通过调控线粒体功能、内质网、PI3K/AKT、Nrf-2、NF-κB等通路调节ROS,改善氧化应激并治疗糖脂代谢疾病;细胞与动物实验证实有效,但安全性与临床证据仍需完善。

要点

  • 植物药经多机制、多层面调控ROS,改善糖脂代谢紊乱。
  • 线粒体、内质网、PI3K/AKT、Nrf-2、NF-κB为关键通路。
  • 细胞与动物实验有效,临床安全性与应用证据待补充。

核心结论

  • 植物药调控ROS具有多机制和多层面的特点。
  • 细胞研究和动物实验均证实植物药通过调控ROS治疗糖脂代谢疾病有效。
  • 安全性研究需进一步完善,临床应用需更多研究支持。

研究设计与样本

  • 检索Web of Science和PubMed数据库2013至2022年相关文献进行综述。
  • 检索词包括herb*、plant medicine、Chinese herbal medicine、ROS、glucose and lipid metabolism等。

主要发现

  • 植物药通过调节线粒体功能、内质网、PI3K/AKT、Nrf-2、NF-κB等信号通路调控ROS。
  • 植物药通过调控ROS改善氧化应激并治疗糖脂代谢疾病。

临床怎么用

  • 植物药可作为调控ROS治疗糖脂代谢疾病的有价值手段。

局限性

  • 安全性研究需进一步完善。
  • 需要更多研究支持植物药的临床应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The incidence of glycolipid metabolic diseases is extremely high worldwide, which greatly hinders people's life expectancy and patients' quality of life. Oxidative stress (OS) aggravates the development of diseases in glycolipid metabolism. Radical oxygen species (ROS) is a key factor in the signal transduction of OS, which can regulate cell apoptosis and contribute to inflammation. Currently, chemotherapies are the main method to treat disorders of glycolipid metabolism, but this can lead to drug resistance and damage to normal organs. Botanical drugs are an important source of new drugs. They are widely found in nature with availability, high practicality, and low cost. There is increasing evidence that herbal medicine has definite therapeutic effects on glycolipid metabolic diseases. Objective: This study aims to provide a valuable method for the treatment of glycolipid metabolic diseases with botanical drugs from the perspective of ROS regulation by botanical drugs and to further promote the development of effective drugs for the clinical treatment of glycolipid metabolic diseases. Methods: Using herb*, plant medicine, Chinese herbal medicine, phytochemicals, natural medicine, phytomedicine, plant extract, botanical drug, ROS, oxygen free radicals, oxygen radical, oxidizing agent, glucose and lipid metabolism, saccharometabolism, glycometabolism, lipid metabolism, blood glucose, lipoprotein, triglyceride, fatty liver, atherosclerosis, obesity, diabetes, dysglycemia, NAFLD, and DM as keywords or subject terms, relevant literature was retrieved from Web of Science and PubMed databases from 2013 to 2022 and was summarized. Results: Botanical drugs can regulate ROS by regulating mitochondrial function, endoplasmic reticulum, phosphatidylinositol 3 kinase (PI3K)/protein kinase B (AKT), erythroid 2-related factor 2 (Nrf-2), nuclear factor κB (NF-κB), and other signaling pathways to improve OS and treat glucolipid metabolic diseases. Conclusion: The regulation of ROS by botanical drugs is multi-mechanism and multifaceted. Both cell studies and animal experiments have demonstrated the effectiveness of botanical drugs in the treatment of glycolipid metabolic diseases by regulating ROS. However, studies on safety need to be further improved, and more studies are needed to support the clinical application of botanical drugs.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Luo M, Zheng Y, Tang S, et al. Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism. Front Pharmacol. 2023. PMID: 37251336. doi:10.3389/fphar.2023.1166178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。